For patients whose cycles were canceled due to COVID-19

The HEARTFELT program provides medication replacement for eligible cash-paying patients, or up to $250 in assistance towards co-pay costs for eligible commercially-insured patients whose controlled ovarian stimulation (COS) cycles were canceled as a result of COVID-19 and who are initiating a new treatment cycle. This program ends December 31, 2020. Terms and conditions apply.

*Certain restrictions may apply. Federal healthcare program beneficiaries, including but not limited to state Medicaid and state Medicaid managed care recipients are ineligible for the program.